Article

Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma

2023-09-28

Abstract excerpt

<title>Abstract</title> <italic><bold>Introduction</bold></italic>: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide. Lack of biomarkers for early diagnosis and follow up after treatment is one of the clinical obstacles for effective treatment of HCC. DNA methylation has been proposed to be a potential biomarker in HCC. However, there is still lacking of evidence of its clinical use....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0486d365-b3c6-591c-9036-b80859699a7f
DOI: 10.21203/rs.3.rs-3378326/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-3378326/v1Read

Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinomaSemantic proximity Read

CpG island methylator phenotype in plasma is associated with hepatocellular carcinoma prognosis.Semantic proximity Read

Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNASemantic proximity Read

Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular markerSemantic proximity Read

Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.Semantic proximity Read

Aberrant Methylation ofAPC, MGMT, RASSF2A, andWif-1Genes in Plasma as a Biomarker for Early Detection of Colorectal CancerSemantic proximity Read

Epigenetic alteration: new insights moving from tissue to plasma – the example of PCDH10 promoter methylation in colorectal cancerSemantic proximity Read

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trialsSemantic proximity Read

Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancerSemantic proximity Read

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular CarcinomaSemantic proximity Read

HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinomaSemantic proximity Read

[Genetic detection and clinical applications in patients with hepatocellular carcinoma].Semantic proximity Read